Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Marc McGowan"'
Autor:
Ekman, Zeinab Kosibaty, Odd Terje Brustugun, Inger Johanne Zwicky Eide, Georgios Tsakonas, Oscar Grundberg, Luigi De Petris, Marc McGowan, Per Hydbring, Simon
Publikováno v:
Cancers; Volume 14; Issue 14; Pages: 3430
Treatment with the tyrosine kinase inhibitor (TKI) osimertinib is the standard of care for non-small cell lung cancer (NSCLC) patients with activating mutations in the epidermal growth factor receptor (EGFR). Osimertinib is also used in T790M-positiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=multidiscipl::cfcd6d0c6482ecd0aeddc7c80c6b1c93
Autor:
Zeinab, Kosibaty, Odd Terje, Brustugun, Inger Johanne, Zwicky Eide, Georgios, Tsakonas, Oscar, Grundberg, Luigi, De Petris, Marc, McGowan, Per, Hydbring, Simon, Ekman
Publikováno v:
Cancers. 14(14)
Treatment with the tyrosine kinase inhibitor (TKI) osimertinib is the standard of care for non-small cell lung cancer (NSCLC) patients with activating mutations in the epidermal growth factor receptor (EGFR). Osimertinib is also used in T790M-positiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::cbb293cba47712960345d78f005636b2
https://pubmed.ncbi.nlm.nih.gov/35884490
https://pubmed.ncbi.nlm.nih.gov/35884490
Autor:
John F. Imbery, Julia Heinzelbecker, Jenny K. Jebsen, Marc McGowan, Camilla Myklebust, Nunzio Bottini, Stephanie M. Stanford, Sigrid S. Skånland, Anders Tveita, Geir E. Tjønnfjord, Ludvig A. Munthe, Peter Szodoray, Britt Nakken
Publikováno v:
British journal of haematology. 198(3)
Chronic lymphocytic leukaemia (CLL) is characterised by malignant mature-like B cells. Supportive to CLL cell survival is chronic B-cell receptor (BCR) signalling; however, emerging evidence demonstrates CLL cells proliferate in response to T-helper
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a58f6701dbcd718d9029292f1c8cfefa
https://pubmed.ncbi.nlm.nih.gov/35655388
https://pubmed.ncbi.nlm.nih.gov/35655388